Quote | Celularity Inc. (NASDAQ:CELU)
Last: | $3.09 |
---|---|
Change Percent: | -6.08% |
Open: | $3.33 |
Close: | $3.29 |
High: | $3.33 |
Low: | $3.01 |
Volume: | 41,268 |
Last Trade Date Time: | 05/06/2024 03:00:00 am |
News | Celularity Inc. (NASDAQ:CELU)
FLORHAM PARK, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today it will host ...
2024-04-19 17:33:58 ET More on Celularity Financial information for Celularity Read the full article on Seeking Alpha For further details see: Celularity receives Nasdaq notice regarding late Form 10-K filing
Message Board Posts | Celularity Inc. (NASDAQ:CELU)
Subject | By | Source | When |
---|---|---|---|
Hey, LandToSea ! $CELU on my radar. | crudeoil24 | investorshub | 04/24/2023 1:05:27 AM |
Hey Crude! Are you no longer following CELU? | LandToSea | investorshub | 04/20/2023 6:53:07 PM |
znewcar1: $CELU 20% v1,0M c2.26 f142M H2.31 ML1.67 | znewcar1 | investorshangout | 10/12/2022 8:49:23 PM |
znewcar1: CELU 27% v1,15M c7.34 f137,7M H8.98 ML=YL$5.5 | znewcar1 | investorshangout | 05/15/2022 2:44:54 AM |
SEC 424B3 > Up to 22,874,999 Shares of | crudeoil24 | investorshub | 12/27/2021 3:07:40 PM |
News, Short Squeeze, Breakout and More Instantly...
Celularity Inc. Company Name:
CELU Stock Symbol:
NASDAQ Market:
FLORHAM PARK, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today it will host ...
FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that on April 17, 2024, the C...
FLORHAM PARK, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, today announced that its abstract entitled “Emerging...